A pharmacovigilance analysis of the EudraVigilance database recorded 102 suicidal events across all GLP-1 medications
Andersen AD, Binzer M, Stenager E, Gramsbergen JB
Risk factors include: Marketing claims that imply treatment or disease prevention Distribution models that resemble commercial drug supply chains Reliance on informal interpretations of regulatory shifts Expanding operations based on speculation can create enforcement exposure
FNDC5 may play a role in neuronal differentiation and genesis (Hashemi et al., 2013
Laser treatments like Fraxel and Picoway as well as topical treatments can offer a localized treatment of melasma, but for a widespread effect, tranexamic acid can also hold potential
Semaglutide affects blood pressure, but its impact varies from person to person